Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Olema Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $291.2K in total
- Insiders trading
- 1
- Net value
- −$291.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Olema Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| O'Byrne Jason | CHIEF FINANCIAL OFFICER | – | Sep 2, 2026 | 1 |
| Harmon Cyrus | Director | 702,770 | Jul 27, 2026 | 5 |
| Biotechnology Value Fund L P | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF Partners L P | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF Inc | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| Biotechnology Value Fund II LP | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| Lampert Mark N | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| Biotechnology Value Trading Fund OS LP | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF Partners OS Ltd. | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF I GP LLC | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF II GP LLC | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| BVF GP Holdings LLC | Director, Other: See Explanation of Responses | 347,970 | Jun 23, 2026 | 1 |
| Rappaport Andrew | Director | 0 | Jun 23, 2026 | 2 |
| Butitta Cynthia M | Director | – | Jun 23, 2026 | 1 |
| Clark Ian T | Director | 0 | Jun 23, 2026 | 2 |
| Garland J. Scott | Director | – | Jun 23, 2026 | 1 |
| Horning Sandra | Director | – | Jun 23, 2026 | 1 |
| Graham G. Walmsley | Director | 700,761Indirect | Jun 23, 2026 | 1 |
| Larson Yi | Director | – | Jun 23, 2026 | 1 |
| Hrustanovic Gorjan | Director | – | Jun 23, 2026 | 1 |
| Raman Prakash | Director | – | Jun 23, 2026 | 2 |
| Mitchell Shawnte | CHIEF LEGAL OFFICER | 0 | Mar 5, 2026 | 2 |
| Austin Sasha Lu | VP of Finance and Controller | 16,188 | Feb 17, 2026 | 1 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 542,761 | Feb 4, 2026 | 3 |
| Bohen Sean | PRESIDENT AND CEO | 237,650 | Feb 4, 2026 | 2 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 4,488 | Feb 4, 2026 | 2 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 139,727 | Jan 15, 2026 | 3 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 4,300,000Indirect | Jan 13, 2025 | 0 |
| Bain Capital Life Sciences IV General Partner, LLC | 10% Owner | 4,300,000Indirect | Jan 13, 2025 | 0 |
| Bain Capital Life Sciences Fund IV, L.P. | 10% Owner | 4,300,000Indirect | Jan 13, 2025 | 0 |
| Bain Capital Life Sciences Opportunities IV, L.P. | 10% Owner | 4,300,000Indirect | Jan 13, 2025 | 0 |
| Bain Capital Life Sciences Opportunities IV GP, LLC | 10% Owner | 4,300,000Indirect | Jan 13, 2025 | 0 |
| Paradigm BioCapital International Fund Ltd. | 10% Owner | 783,118Indirect | Aug 5, 2024 | 0 |
| Paradigm Biocapital Advisors LP | 10% Owner | 783,118Indirect | Aug 5, 2024 | 0 |
| Paradigm BioCapital Advisors GP LLC | 10% Owner | 783,118Indirect | Aug 5, 2024 | 0 |
| Asefaw Senai | 10% Owner | 783,118Indirect | Aug 5, 2024 | 0 |
| Moriarty John B | EVP, Ch. Legal Officer & Sec. | – | Feb 2, 2023 | 0 |
| Horn Kinney | Chief Business Officer | 2,458 | Feb 2, 2023 | 0 |
| Kushner Peter J. | CHIEF SCIENTIFIC OFFICER | – | Feb 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 8 | 1 day | Harmon CyrusDirector | SSale | −10.0K | $6.30 | −$63.0K | −1.0%1.04M after | |
| Jun 7, 2023 (view filing) | Jun 5-6 | 2 days | Harmon CyrusDirector | SSale | −10.0K | $6.18 | −$61.8K | −0.9%1.05M after | 2 lots |
| Apr 7, 2023 (view filing) | Apr 6 | 1 day | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | PPurchase | +10.0K | – | – | +2.6%396.2K after | |
| Sep 23, 2022 (view filing) | Sep 21 | 2 days | Bohen SeanPRESIDENT AND CEO | PPurchase | +20.0K | – | – | +36.8%74.3K after | Amended |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | PPurchase | +20.0K | – | – | +5.5%381.2K after | |
| Jun 14, 2022 (view filing)4:46 PM ET | Jun 10 | 4 days | Biotechnology Value Fund L P and 9 othersDirector, Other: See Explanation of Responses | PPurchaseCommon stock, $0.0001 par value | +200.0K | $4.03 | +$806.9K | +7.4%2.91M after | 2 lots |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $4.75 | −$25.0K | −68.1%2.46K after | |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $6.85 | −$36.0K | −68.1%2.46K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $10.39 | −$54.6K | −68.1%2.46K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Myles David C.CHIEF DEVELOPMENT OFFICER | SSale | −10.0K | $10.30 | −$103.0K | −1.7%582.9K after | |
| Dec 2, 2021 (view filing)8:45 PM ET | Nov 30 | 2 days | BVF Partners L P and 9 othersDirector, 10% Owner | PPurchaseCommon stock, $0.0001 par value | +739.7K | $9.39 | +$6.95M | New position471.4K after | 3 lots |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Harmon CyrusCHIEF TECHNOLOGY OFFICER | SSale | −400 | $24.76 | −$9.90K | 0.0%1.05M after | |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −27.7K | $26.88 | −$743.7K | −93.9%1.79K after | |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Harmon CyrusCHIEF TECHNOLOGY OFFICER | SSale | −12.0K | $27.98 | −$335.8K | −1.1%1.05M after | 2 lots |
| Oct 15, 2021 (view filing) | Oct 14 | 1 day | Bohen SeanPRESIDENT AND CEO | SSale | −5.00K | $30.47 | −$152.4K | −8.7%52.5K after | 2 lots |
| Oct 12, 2021 (view filing) | Oct 11 | 1 day | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $27.90 | −$146.5K | −74.6%1.79K after | 2 lots |
| Sep 29, 2021 (view filing) | Sep 27 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −1.08K | $30.07 | −$32.6K | −2.0%52.5K after | |
| Sep 21, 2021 (view filing) | Sep 20 | 1 day | Harmon CyrusCHIEF TECHNOLOGY OFFICER | SSale | −12.0K | $26.30 | −$315.6K | −1.1%1.06M after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $29.38 | −$154.3K | −74.6%1.79K after | |
| Sep 9, 2021 (view filing) | Sep 7-8 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −3.04K | $30.01 | −$91.4K | −5.5%52.5K after | 2 lots |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −871 | $30.05 | −$26.2K | −1.6%54.3K after | |
| Aug 20, 2021 (view filing) | Aug 19 | 1 day | Harmon CyrusCHIEF TECHNOLOGY OFFICER | SSale | −12.0K | $24.97 | −$299.6K | −1.1%1.08M after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $25.71 | −$135.0K | −74.6%1.79K after | 2 lots |
| Jul 21, 2021 (view filing) | Jul 19-20 | 2 days | Harmon CyrusCHIEF TECHNOLOGY OFFICER | SSale | −12.0K | $25.10 | −$301.3K | −1.1%1.09M after | 2 lots |
| Jul 13, 2021 (view filing) | Jul 12 | 1 day | Horn KinneyCHIEF BUSINESS OFFICER | SSale | −5.25K | $26.51 | −$139.2K | −74.6%1.79K after | 2 lots |